108 related articles for article (PubMed ID: 20224653)
61. Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience.
Madabhavi I; Sarkar M; Modi M; Kadakol N
J Glob Oncol; 2019 Sep; 5():1-11. PubMed ID: 31584851
[TBL] [Abstract][Full Text] [Related]
62. Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center.
Moura AC; Delamain MT; Duarte GBO; Lorand-Metze I; Souza CA; Pagnano KBB
Hematol Transfus Cell Ther; 2019; 41(2):125-128. PubMed ID: 31079659
[TBL] [Abstract][Full Text] [Related]
63. Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literature.
Sgherza N; Abruzzese E; Perla G; Minervini MM; Chiello V; Sciannamè N; Cascavilla N
Ther Clin Risk Manag; 2017; 13():751-755. PubMed ID: 28721056
[TBL] [Abstract][Full Text] [Related]
64. The impact of dasatinib on pregnancy outcomes.
Cortes JE; Abruzzese E; Chelysheva E; Guha M; Wallis N; Apperley JF
Am J Hematol; 2015 Dec; 90(12):1111-5. PubMed ID: 26348106
[TBL] [Abstract][Full Text] [Related]
65. Tyrosine kinase inhibitors and pregnancy.
Abruzzese E; Trawinska MM; Perrotti AP; De Fabritiis P
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014028. PubMed ID: 24804001
[TBL] [Abstract][Full Text] [Related]
66. Acute lymphoblastic leukemia in pregnancy: a case report with literature review.
Ticku J; Oberoi S; Friend S; Busowski J; Langenstroer M; Baidas S
Ther Adv Hematol; 2013 Oct; 4(5):313-9. PubMed ID: 24082992
[TBL] [Abstract][Full Text] [Related]
67. Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester.
Bayraktar S; Morency B; Escalón MP
BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22791487
[TBL] [Abstract][Full Text] [Related]
68. A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13).
Kumar S; Apostolova M; Woolley PV
Hematol Rep; 2011 Oct; 3(3):e27. PubMed ID: 22593818
[TBL] [Abstract][Full Text] [Related]
69. Dasatinib: from treatment of imatinib-resistant or -intolerant patients with chronic myeloid leukemia to treatment of patients with newly diagnosed chronic phase chronic myeloid leukemia.
Abbott BL
Clin Ther; 2012 Feb; 34(2):272-81. PubMed ID: 22285209
[TBL] [Abstract][Full Text] [Related]
70. Targeted chronic myeloid leukemia therapy: Seeking a cure.
Fausel C
Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S9-15. PubMed ID: 18056932
[TBL] [Abstract][Full Text] [Related]
71. Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy.
Conchon M; Sanabani SS; Serpa M; Novaes MM; Nardinelli L; Ferreira PB; Dorliac-Llacer PE; Bendit I
Adv Hematol; 2010; 2010():136252. PubMed ID: 20224653
[TBL] [Abstract][Full Text] [Related]
72. Successful pregnancy and delivery in a patient with chronic myeloid leukemia: a case report and review of the literature.
Sheng W; Sun N
Springerplus; 2016; 5(1):2055. PubMed ID: 27995032
[TBL] [Abstract][Full Text] [Related]
73. Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.
Conchon M; Sanabani SS; Bendit I; Santos FM; Serpa M; Dorliac-Llacer PE
J Hematol Oncol; 2009 Oct; 2():42. PubMed ID: 19807918
[TBL] [Abstract][Full Text] [Related]
74. [Pregnancy and myeloid leukemia treated with imatinib. Development and monitoring of a patient].
Báez-de la Fuente E; Arellano-Severiano B
Rev Med Inst Mex Seguro Soc; 2014; 52(3):342-5. PubMed ID: 24878098
[TBL] [Abstract][Full Text] [Related]
75. [A female chronic myeloid leukemia patient who gave birth after stopping imatinib intentionally but who maintained a major molecular response with interferon].
Osawa T; Takahashi T; Yasuda M; Umeda M; Nagaya K; Tachi T; Goto H; Kasahara S; Teramachi H; Goto C
Gan To Kagaku Ryoho; 2015 Apr; 42(4):477-9. PubMed ID: 25963696
[TBL] [Abstract][Full Text] [Related]
76. Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety.
Huang X; Jiang Q; Hu J; Li J; Jin J; Meng F; Shen Z; Liu T; Wu D; Wang J; Wang J
Front Med; 2019 Jun; 13(3):344-353. PubMed ID: 30159669
[TBL] [Abstract][Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
